The Organon Access Program may be able to help answer questions about access and support, including:
- Benefit investigations and information about prior authorizations and appeals
- Co-pay assistance for eligible patients
- Referral to the Organon Patient Assistance Program for eligibility determination (provided through the Organon Patient Assistance Program Inc.)
- Billing and coding
Click on the Medication Below for Information or to Enroll:
BILDYOS®
(denosumab-nxxp) injection 60 mg/mL
Before prescribing BILDYOS, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.
BILPREVDA®
(denosumab-nxxp) injection 120 mg/1.7 mL
Before prescribing BILPREVDA, please read the Prescribing Information.
ONTRUZANT®
(trastuzumab-dttb) for injection, for intravenous use 21 mg/mL
Before prescribing ONTRUZANT, please read the Prescribing Information, including the Boxed Warning.
RENFLEXIS®
(infliximab-abda) for injection, for intravenous use 100 mg
Before prescribing RENFLEXIS, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.
TOFIDENCE®
(tocilizumab-bavi) injection, for intravenous use
Before prescribing TOFIDENCE, please read the Prescribing Information, including the Boxed Warning. The Medication Guide also is available.
Other Organon Support Programs
NEXPLANON®
(etonogestrel implant) 68 mg Radiopaque